Neuro-immune interactions, including neuroinflammation or autoimmunity, play critical roles in many central nervous system (CNS) disorders, including multiple sclerosis (MS). MS is a neuroinflammatory and autoimmune disease characterized by aberrant immune cell infiltration, leading to inflammation and subsequent demyelination in the CNS. Even though there’s currently no cure, drugs have been developed to target autoimmunity and successfully manage the disease.
An accepted model that is being used to help monitor disease progression in response to these drugs is Experimental Autoimmune Encephalomyelitis (EAE). This webinar examines the intricacies of EAE and decode the mechanisms before and after certain treatments, from gene expression profiling to advanced neuroimaging and behavioral testing.
Jussi Toivanen, MSc
In Vivo Scientist
Robert Nunan, PhD
Group Leader, IO & Neuroinflammation, Cell Biology
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.